Literature DB >> 19335652

Carcinogenicity of acetaldehyde in alcoholic beverages: risk assessment outside ethanol metabolism.

Dirk W Lachenmeier1, Fotis Kanteres, Jürgen Rehm.   

Abstract

AIMS: In addition to being produced in ethanol metabolism, acetaldehyde occurs naturally in alcoholic beverages. Limited epidemiological evidence points to acetaldehyde as an independent risk factor for cancer during alcohol consumption, in addition to the effects of ethanol. This study aims to estimate human exposure to acetaldehyde from alcoholic beverages and provide a quantitative risk assessment.
METHODS: The human dietary intake of acetaldehyde via alcoholic beverages was estimated based on World Health Organization (WHO) consumption data and literature on the acetaldehyde contents of different beverage groups (beer, wine, spirits and unrecorded alcohol). The risk assessment was conducted using the European Food Safety Authority's margin of exposure (MOE) approach with benchmark doses obtained from dose-response modelling of animal experiments. Life-time cancer risk was calculated using the T25 dose descriptor.
RESULTS: The average exposure to acetaldehyde from alcoholic beverages was estimated at 0.112 mg/kg body weight/day. The MOE was calculated to be 498, and the life-time cancer risk at 7.6 in 10,000. Higher risk may exist for people exposed to high acetaldehyde contaminations, as we have found in certain unrecorded alcohol beverages in Guatemala and Russia, for which we have demonstrated possible exposure scenarios, with risks in the range of 1 in 1000.
CONCLUSIONS: The life-time cancer risks for acetaldehyde from alcoholic beverages greatly exceed the usual limits for cancer risks from the environment set between 1 : 10,000 and 1 : 1,000,000. Alcohol consumption has thus been identified as a direct source of acetaldehyde exposure, which in conjunction with other sources (food flavourings, tobacco) results in a magnitude of risk requiring intervention. An initial public health measure could be to reduce the acetaldehyde content in alcoholic beverages as low as technologically possible, and to restrict its use as a food flavour additive.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19335652     DOI: 10.1111/j.1360-0443.2009.02516.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  33 in total

1.  The relation between different dimensions of alcohol consumption and burden of disease: an overview.

Authors:  Jürgen Rehm; Dolly Baliunas; Guilherme L G Borges; Kathryn Graham; Hyacinth Irving; Tara Kehoe; Charles D Parry; Jayadeep Patra; Svetlana Popova; Vladimir Poznyak; Michael Roerecke; Robin Room; Andriy V Samokhvalov; Benjamin Taylor
Journal:  Addiction       Date:  2010-03-15       Impact factor: 6.526

2.  Hypersensitivities for acetaldehyde and other agents among cancer cells null for clinically relevant Fanconi anemia genes.

Authors:  Soma Ghosh; Surojit Sur; Sashidhar R Yerram; Carlo Rago; Anil K Bhunia; M Zulfiquer Hossain; Bogdan C Paun; Yunzhao R Ren; Christine A Iacobuzio-Donahue; Nilofer A Azad; Scott E Kern
Journal:  Am J Pathol       Date:  2013-11-06       Impact factor: 4.307

3.  Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.

Authors:  Ellen L Goode; Kristin L White; Robert A Vierkant; Catherine M Phelan; Julie M Cunningham; Joellen M Schildkraut; Andrew Berchuck; Melissa C Larson; Brooke L Fridley; Janet E Olson; Penelope M Webb; Xiaoqing Chen; Jonathan Beesley; Georgia Chenevix-Trench; Thomas A Sellers
Journal:  Mol Carcinog       Date:  2010-12-28       Impact factor: 4.784

4.  Prospective study of alcohol consumption quantity and frequency and cancer-specific mortality in the US population.

Authors:  Rosalind A Breslow; Chiung M Chen; Barry I Graubard; Kenneth J Mukamal
Journal:  Am J Epidemiol       Date:  2011-09-30       Impact factor: 4.897

5.  Association between RAD51 polymorphisms and susceptibility of head and neck cancer: a meta-analysis.

Authors:  Fanliang Kong; Jin Wu; Lixia Hu; Yingying Du; Yueyin Pan
Journal:  Int J Clin Exp Med       Date:  2015-04-15

6.  Alcohol Intake and Risk of Incident Melanoma: A Pooled Analysis of Three Prospective Studies in the United States.

Authors:  Andrew Rivera; Hongmei Nan; Tricia Li; Abrar Qureshi; Eunyoung Cho
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-12       Impact factor: 4.254

7.  Potential Adverse Public Health Effects Afforded by the Ingestion of Dietary Lipid Oxidation Product Toxins: Significance of Fried Food Sources.

Authors:  Martin Grootveld; Benita C Percival; Justine Leenders; Philippe B Wilson
Journal:  Nutrients       Date:  2020-04-01       Impact factor: 5.717

Review 8.  Cancer risk assessment of ethyl carbamate in alcoholic beverages from Brazil with special consideration to the spirits cachaça and tiquira.

Authors:  Dirk W Lachenmeier; Maria C P Lima; Ian C C Nóbrega; José A P Pereira; Florence Kerr-Corrêa; Fotis Kanteres; Jürgen Rehm
Journal:  BMC Cancer       Date:  2010-06-08       Impact factor: 4.430

Review 9.  Research recommendations for selected IARC-classified agents.

Authors:  Elizabeth M Ward; Paul A Schulte; Kurt Straif; Nancy B Hopf; Jane C Caldwell; Tania Carreón; David M DeMarini; Bruce A Fowler; Bernard D Goldstein; Kari Hemminki; Cynthia J Hines; Kirsti Husgafvel Pursiainen; Eileen Kuempel; Joellen Lewtas; Ruth M Lunn; Elsebeth Lynge; Damien M McElvenny; Hartwig Muhle; Tamie Nakajima; Larry W Robertson; Nathaniel Rothman; Avima M Ruder; Mary K Schubauer-Berigan; Jack Siemiatycki; Debra Silverman; Martyn T Smith; Tom Sorahan; Kyle Steenland; Richard G Stevens; Paolo Vineis; Shelia Hoar Zahm; Lauren Zeise; Vincent J Cogliano
Journal:  Environ Health Perspect       Date:  2010-06-18       Impact factor: 9.031

10.  Ethyl carbamate in alcoholic beverages from Mexico (tequila, mezcal, bacanora, sotol) and Guatemala (cuxa): market survey and risk assessment.

Authors:  Dirk W Lachenmeier; Fotis Kanteres; Thomas Kuballa; Mercedes G López; Jürgen Rehm
Journal:  Int J Environ Res Public Health       Date:  2009-01-20       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.